Case number 1:23-cv-00685
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 28, 2024 | 63 | Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding Markman Hearing and Deadlines Associated with Claim Construction - re 34 Scheduling Order,,. (Dellinger, Megan) (Entered: 06/28/2024) (1) |
| Jun 21, 2024 | 62 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests to Apotex for the Production of Documents and Things filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) (Entered: 06/21/2024) (3) |
| Jun 20, 2024 | 61 | NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms/Phrases for Construction filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) (Entered: 06/20/2024) (3) |
| Jun 18, 2024 | 60 | NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Initial Claim Terms filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 06/18/2024) (2) |
| Jun 7, 2024 | 59 | NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Apotex Inc. and Apotex Corp. for Its ANDA Product Associate with ANDA No. 218552 for U.S. Patent Nos. 9,486,526 and 10,034,877; and (2) Plaintiffs' Response to Defendants' Invalidity Contentions filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) (Entered: 06/07/2024) (4) |
| Jun 6, 2024 | 58 | NOTICE OF SERVICE of (1) Boehringer's Responses and Objections to Apotex Inc. and Apotex Corp.'s First Set of Rule 33 Interrogatories (Nos. 1-8); and (2) Boehringer's Responses and Objections to Apotex Inc. and Apotex Corp.'s First Set of Requests for Production of Documents and Things (Nos. 1-60) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) (Entered: 06/06/2024) (4) |
| May 30, 2024 | 57 | STIPULATION and [Proposed] Order to Extend Certain Case Deadlines by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 05/30/2024) (2) |
| Apr 30, 2024 | 56 | NOTICE OF SERVICE of (1) Apotex Inc. and Apotex Corp.'s First Set of Rule 33 Interrogatories (Nos. 1-8) and (2) Apotex Inc. and Apotex Corp.'s First Set of Requests for Production of Documents and Things (Nos. 1-60) filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 04/30/2024) (2) |
| Apr 2, 2024 | 55 | NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Initial Noninfringement Contentions Regarding U.S. Patent Nos. 9,486,526 and 10,034,877 and Apotex Inc. and Apotex Corp.'s Initial Invalidity Contentions Regarding U.S. Patent Nos. 9,486,526 and 10,034,877 filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 04/02/2024) (2) |
| Mar 1, 2024 | 54 | SO ORDERED, re 52 Proposed Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI"), filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 3/1/2024. (kmd) (Entered: 03/01/2024) (9) |
| Mar 1, 2024 | 53 | STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 3/1/2024. (kmd) (Entered: 03/01/2024) (30) |
| Mar 1, 2024 | 52 | PROPOSED ORDER -- [Proposed] Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI") -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 03/01/2024) (9) |
| Mar 1, 2024 | 51 | PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 03/01/2024) (30) |
| Feb 27, 2024 | 50 | SO ORDERED, re 49 STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order and a proposed ESI Order to March 1, 2024, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 2/27/2024. (kmd) (Entered: 02/27/2024) (2) |
| Feb 27, 2024 | 49 | STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order and a proposed ESI Order to March 1, 2024 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 02/27/2024) (2) |
| Feb 21, 2024 | 48 | SO ORDERED, re 47 STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order and a proposed ESI Order to February 27, 2024, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 2/21/2024. (kmd) (Entered: 02/21/2024) (2) |
| Feb 20, 2024 | 47 | STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order and a proposed ESI Order to February 27, 2024 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 02/20/2024) (2) |
| Feb 6, 2024 | 46 | SO ORDERED, re 44 STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order and a proposed ESI Order to February 20, 2024, filed by Apotex Inc., Apotex Corp. Signed by Judge Colm F. Connolly on 2/6/2024. (kmd) (Entered: 02/06/2024) (2) |
| Feb 2, 2024 | 45 | REDACTED VERSION of 40 Reply Brief by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 02/02/2024) (17) |
| Feb 1, 2024 | 44 | STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order and a proposed ESI Order to February 20, 2024 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) (Entered: 02/01/2024) (2) |
| Jan 31, 2024 | 43 | REDACTED VERSION of 35 Answering Brief in Opposition, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 01/31/2024) (30) |
| Jan 26, 2024 | 42 | NOTICE OF SERVICE of Plaintiffs' Disclosure of Asserted Claims filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) (Entered: 01/26/2024) (3) |
| Jan 26, 2024 | 41 | REQUEST for Oral Argument by Apotex Corp., Apotex Inc. re 26 MOTION for Judgment on the Pleadings . (Phillips, John) (Entered: 01/26/2024) (1) |
| Jan 26, 2024 | 40 | [SEALED] REPLY BRIEF re 26 MOTION for Judgment on the Pleadings filed by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 01/26/2024) (0) |
| Jan 25, 2024 | 39 | NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); Apotex Inc. and Apotex Corp.'s Paragraph 3 Initial Disclosures filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 01/25/2024) (2) |
| Jan 25, 2024 | 38 | NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) (Entered: 01/25/2024) (3) |
| Jan 24, 2024 | 37 | SO ORDERED, re 36 STIPULATION TO EXTEND TIME for Plaintiffs to submit redacted version of Plaintiffs' Answering Brief in Opposition to Defendants' Motion for Judgment on the Pleadings (D.I. 35) to January 31, 2024, filed by Apotex Inc., Apotex Corp. Signed by Judge Colm F. Connolly on 1/24/2024. (kmd) (Entered: 01/24/2024) (2) |
| Jan 24, 2024 | 36 | STIPULATION TO EXTEND TIME for Plaintiffs to submit redacted version of Plaintiffs' Answering Brief in Opposition to Defendants' Motion for Judgment on the Pleadings (D.I. 35) to January 31, 2024 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) (Entered: 01/24/2024) (2) |
| Jan 17, 2024 | 35 | [SEALED] ANSWERING BRIEF in Opposition re 26 MOTION for Judgment on the Pleadings filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..Reply Brief due date per Local Rules is 1/24/2024. (Dellinger, Megan) (Main Document 35 replaced on 1/18/2024) (nmf, ). (Entered: 01/17/2024) (0) |
| Jan 4, 2024 | 34 | SCHEDULING ORDER: Joinder of Parties due by 2/7/2025. Amended Pleadings due by 2/7/2025. Fact Discovery completed by 2/14/2025. Expert Discovery due by 9/12/2025. Joint Claim Construction Brief due by 9/6/2024. A Markman Hearing is set for 11/8/2024 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 10/22/2025. A Final Pretrial Conference is set for 11/12/2025 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 11/17/2025 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/4/2024. (nmf) (Entered: 01/04/2024) (28) |
| Jan 3, 2024 | 33 | PROPOSED ORDER -- Revised Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # 1 Letter to The Honorable Colm F. Connolly)(Dellinger, Megan) (Entered: 01/03/2024) (0) |
| Dec 21, 2023 | 32 | Official Transcript of Telephonic Scheduling Conference held on December 20, 2023 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: Bonnie_Archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/11/2024. Redacted Transcript Deadline set for 1/22/2024. Release of Transcript Restriction set for 3/20/2024. (nmf) (Entered: 12/21/2023) (14) |
| Dec 20, 2023 | 31 | REDACTED VERSION of 27 Opening Brief in Support by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 12/20/2023) (30) |
| Dec 18, 2023 | 29 | SO ORDERED, re 28 STIPULATION TO EXTEND TIME for Plaintiffs to file their answering brief in opposition to Apotex's Motion for Judgment on the Pleadings (D.I. 26) and for Apotex to file its reply brief in support of its motion to January 17, 2024 and January 26, 22024, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Reset Briefing Schedule: re 26 MOTION for Judgment on the Pleadings. Answering Brief due 1/17/2024. Reply Brief due 1/26/2024. Signed by Judge Colm F. Connolly on 12/18/2023. (kmd) (Entered: 12/18/2023) (2) |
| Dec 18, 2023 | 30 | PROPOSED ORDER -- Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # 1 Letter to Judge Connolly)(Dellinger, Megan) (Entered: 12/18/2023) (0) |
| Dec 15, 2023 | 28 | STIPULATION TO EXTEND TIME for Plaintiffs to file their answering brief in opposition to Apotex's Motion for Judgment on the Pleadings (D.I. 26) and for Apotex to file its reply brief in support of its motion to January 17, 2024 and January 26, 2024, respectively - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 12/15/2023) (2) |
| Dec 13, 2023 | 27 | [SEALED] OPENING BRIEF in Support re 26 MOTION for Judgment on the Pleadings filed by Apotex Corp., Apotex Inc..Answering Brief/Response due date per Local Rules is 12/27/2023. (Phillips, John) (Entered: 12/13/2023) (0) |
| Dec 13, 2023 | 26 | MOTION for Judgment on the Pleadings - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Proposed Order)(Phillips, John) (Entered: 12/13/2023) (0) |
| Dec 11, 2023 | 25 | [SEALED] ANSWER to 15 Answer to Complaint, Counterclaim by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1)(Dellinger, Megan) (Entered: 12/11/2023) (0) |
| Dec 5, 2023 | 24 | SO ORDERED, re 23 STIPULATION TO EXTEND TIME for Plaintiffs to respond to Defendants' Counterclaims (D.I. 15) to December 11, 2023, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Set Answer Deadlines: Boehringer Ingelheim Corporation answer due 12/11/2023; Boehringer Ingelheim International GmbH answer due 12/11/2023; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 12/11/2023; Boehringer Ingelheim Pharmaceuticals Inc. answer due 12/11/2023. Signed by Judge Colm F. Connolly on 12/5/2023. (kmd) (Entered: 12/05/2023) (2) |
| Dec 4, 2023 | 23 | STIPULATION TO EXTEND TIME for Plaintiffs to respond to Defendants' Counterclaims (D.I. 15) to December 11, 2023 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 12/04/2023) (2) |
| Dec 4, 2023 | 22 | MOTION for Pro Hac Vice Appearance of Attorney Greg L. Goldblatt and Ty W. Callahan - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Certification of Greg L. Goldblatt, # 2 Certification of Ty W. Callahan)(Haney, Megan) (Entered: 12/04/2023) (0) |
| Dec 4, 2023 | 21 | MOTION for Pro Hac Vice Appearance of Attorney Rachel Pernic Waldron - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Certification of Rachel Pernic Waldron)(Haney, Megan) (Entered: 12/04/2023) (0) |
| Nov 22, 2023 | 20 | REDACTED VERSION of 15 Answer to Complaint, Counterclaim by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Phillips, John) (Entered: 11/22/2023) (0) |
| Nov 21, 2023 | 19 | SO ORDERED, re 18 STIPULATION TO EXTEND TIME for defendants Apotex Inc. and Apotex Corp. to submit a redacted version of their Answer, Separate Defenses and Counterclaims to Plaintiff's Complaint (D.I. 15) to November 22, 2023, filed by Apotex Inc., Apotex Corp. Signed by Judge Colm F. Connolly on 11/21/2023. (kmd) (Entered: 11/21/2023) (2) |
| Nov 20, 2023 | 18 | STIPULATION TO EXTEND TIME for defendants Apotex Inc. and Apotex Corp. to submit a redacted version of their Answer, Separate Defenses and Counterclaims to Plaintiff's Complaint (D.I. 15) to November 22, 2023 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) (Entered: 11/20/2023) (2) |
| Nov 16, 2023 | 17 | Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 12/20/2023 at 02:30 PM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 11/16/2023. (nmf) (Entered: 11/16/2023) (2) |
| Nov 13, 2023 | 16 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc.; Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 11/13/2023) (2) |
| Nov 13, 2023 | 15 | [SEALED] ANSWER to 2 Complaint, with Jury Demand Separate Defenses, COUNTERCLAIM against All Plaintiffs by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Phillips, John) (Entered: 11/13/2023) (0) |
| Nov 7, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Steven J. Birkos - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Certification of Steven J. Birkos)(Haney, Megan) (Entered: 11/07/2023) (0) |
| Nov 3, 2023 | 13 | MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Certification of William A. Rakoczy)(Haney, Megan) (Entered: 11/03/2023) (0) |
| Nov 2, 2023 | 12 | STIPULATION TO EXTEND TIME for defendants Apotex Inc. and Apotex Corp. to answer, move or otherwise respond to Plaintiffs' Complaint (D.I. 2) to November 13, 2023 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) (Entered: 11/02/2023) (2) |
| Sep 8, 2023 | 11 | WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Apotex Corp. waiver sent on 9/5/2023, answer due 11/6/2023. (Dellinger, Megan) (Entered: 09/08/2023) (1) |
| Sep 8, 2023 | 10 | WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Apotex Inc. waiver sent on 9/5/2023, answer due 11/6/2023. (Dellinger, Megan) (Entered: 09/08/2023) (1) |
| Jun 30, 2023 | 9 | REDACTED VERSION of 2 Complaint, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-2)(Dellinger, Megan) (Entered: 06/30/2023) (Exhibits 1-2) (30) |
| Jun 30, 2023 | 9 | REDACTED VERSION of 2 Complaint, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-2)(Dellinger, Megan) (Entered: 06/30/2023) (Main Document) (12) |
| Jun 28, 2023 | 8 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 06/28/2023) (2) |
| Jun 28, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 06/28/2023) (0) |
| Jun 26, 2023 | N/A | Remark: Case submitted for routine judicial assignment. (jfm) (Entered: 06/27/2023) (0) |
| Jun 26, 2023 | N/A | ORAL ORDER granting 1 MOTION to Seal. A redacted version shall be filed within seven days. Ordered by Judge Colm F. Connolly on 6/26/2023. (nmf) (Entered: 06/26/2023) (0) |
| Jun 23, 2023 | 1 | MOTION for Leave to File Complaint Under Seal - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(jfm) (Entered: 06/23/2023) (Text of Proposed Order) (1) |
| Jun 23, 2023 | N/A | Remark: Exit electronic copies to Judge, CFC. (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | 7 | Summonses Issued (please complete the top portion of the form and print out for use/service). (jfm) (Entered: 06/23/2023) (2) |
| Jun 23, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (jfm) (Entered: 06/23/2023) (2) |
| Jun 23, 2023 | 5 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,486,526B2; 10,034,877B2. (jfm) (Entered: 06/23/2023) (1) |
| Jun 23, 2023 | 4 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 9, 2023. Date of Expiration of Patent: August 5, 2029. (Entered: 06/23/2023) (1) |
| Jun 23, 2023 | 3 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 06/23/2023) (3) |
| Jun 23, 2023 | 2 | [SEALED] COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 402, receipt number BDEDC-4164905.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet)(jfm) (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | 1 | MOTION for Leave to File Complaint Under Seal - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(jfm) (Entered: 06/23/2023) (Main Document) (3) |
